Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases

Clinical trial NCT06688799 · RECRUITING

Trial details

NCT number: NCT06688799
Sponsor: Beijing GoBroad Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2024-11-23
Primary completion: 2026-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.